Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The hemostatic system and angiogenesis in malignancy.

M Z Wojtukiewicz1, E Sierko, P Klement

  • 1Department of Oncology, Medical Academy, Bialystok, Poland.

Neoplasia (New York, N.Y.)
|November 1, 2001
PubMed
Summary

Cancer growth involves blood coagulation and fibrinolysis, which influence tumor angiogenesis. Targeting these hemostatic processes and using inhibitors like angiostatin may offer new anti-cancer treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum: Centrality-Dependent Modification of Jet-Production Rates in Deuteron-Gold Collisions at sqrt[s_{NN}]=200  GeV [Phys. Rev. Lett. 116, 122301 (2016)].

Physical review letters·2025
Same author

Measurement of Direct-Photon Cross Section and Double-Helicity Asymmetry at sqrt[s]=510  GeV in p[over →]+p[over →] Collisions.

Physical review letters·2023
Same author

Λ_{c}^{+} Production and Baryon-to-Meson Ratios in pp and p-Pb Collisions at sqrt[s_{NN}]=5.02  TeV at the LHC.

Physical review letters·2021
Same author

Soft-Dielectron Excess in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2021
Same author

Elliptic Flow of Electrons from Beauty-Hadron Decays in Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2021
Same author

Measurement of the Low-Energy Antideuteron Inelastic Cross Section.

Physical review letters·2020

Area of Science:

  • Oncology
  • Hematology
  • Molecular Biology

Background:

  • Coagulopathy and angiogenesis are consistent host responses in cancer.
  • These processes, previously considered separate, are functionally linked.
  • The hemostatic system significantly impacts tumor angiogenesis and cancer progression.

Purpose of the Study:

  • To explore the intricate relationship between hemostasis and tumor angiogenesis.
  • To understand how hemostatic factors influence cancer growth.
  • To identify potential therapeutic targets within the hemostatic system for cancer treatment.

Main Methods:

  • Review of existing literature on hemostasis and cancer.
  • Analysis of the roles of specific hemostatic factors (tissue factor, thrombin, fibrin, etc.) in angiogenesis.
  • Investigation of endogenous angiogenesis inhibitors derived from hemostatic proteins.

Main Results:

  • Blood coagulation and fibrinolysis directly influence tumor angiogenesis.
  • Hemostatic system components (e.g., tissue factor, thrombin, platelets) regulate tumor angiogenesis through standard and non-standard functions.
  • Proteolytic cleavage of hemostatic proteins releases angiogenesis inhibitors like angiostatin and antiangiogenic antithrombin III (aaATIII).

Conclusions:

  • The hemostatic system plays a dual role in promoting or inhibiting angiogenesis, affecting the overall angiogenic balance in tumors.
  • Targeted inhibition of pro-angiogenic hemostatic activities and utilization of endogenous inhibitors are promising anti-cancer strategies.
  • Further research is needed to fully elucidate the complex mechanisms involved.

Related Experiment Videos